Results 61 to 70 of about 11,769,643 (158)
Psychedelics, entactogens and psychoplastogens for depression and related disorders
Currently, the most actively investigated rapidly acting antidepressants, anxiolytics and/or anti PTSD agents, include psychedelics e.g. psilocybin, LSD, N,N‐dimethyltryptamine, ayahuasca; non‐hallucinogenic entactogens, e.g. MDMA; psychoplastogens which rapidly promote neuroplasticity, e.g.
Daniel Hoyer
wiley +1 more source
Background and Purpose Serotonergic psychedelic drugs are under investigation as therapies for various psychiatric disorders, including major depression. Although serotonergic psychedelic drugs are 5‐HT2A receptor agonists, some such agonists are not psychedelic, potentially due to differences in 5‐HT2A receptor ligand bias or signalling efficacy. Here,
Aurelija Ippolito +6 more
wiley +1 more source
IntroductionPsychedelic agents have regained the attention of pharmaceutical companies as promising treatments for depressive episodes. 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT), an atypical psychedelic, is emerging as a potentially effective, novel ...
Aleksander Kwaśny +2 more
doaj +1 more source
Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
Psychedelic drugs that activate 5‐HT2A receptors have been long used for cultural, medicinal and recreational purposes. Interest in psychedelics for treating psychiatric disorders has resurged recently and is well documented; less well recognised are their anti‐inflammatory properties. Growing evidence now demonstrates that psychedelics modulate immune
Omar Qureshi +10 more
wiley +1 more source
Cerebral organoids are transforming brain research, yet the field remains fragmented. This comprehensive systematic review maps 738 studies published between 2014 and 2024 to uncover trends, gaps, and opportunities across neuroscience. Introducing OrganoidMap—an interactive, open‐access platform to explore and compare models—this work enables ...
Anna Wolfram +10 more
wiley +1 more source
Psychedelics and immunomodulation: Novel approaches and therapeutic opportunities
Classical psychedelics are psychoactive substances, which, besides their psychopharmacological activity, have also been shown to exert significant modulatory effects on immune responses by altering signaling pathways involved in inflammation, cellular ...
Attila eSzabo
doaj +1 more source
Depression and substance use disorder are difficult to treat, prompting interest in psychedelics like DMT, though its neural mechanisms remain unclear. This ex vivo study examined acute DMT effects on electrophysiology in male and female Ih‐negative neurons of the mouse ventral tegmental area (VTA). Low‐dose DMT (500 nM) had no effect, whereas a higher
Jannik Nicklas Eliasen +3 more
wiley +1 more source
In psychiatry, the term flashback is widely recognized in relation to post‐traumatic stress disorder (PTSD) as well as in the characterization of post‐psychedelic experiences. Although it is now most commonly associated with PTSD, the term was originally introduced in the context of psychedelics.
Ricarda Evens
wiley +1 more source
Psilocybin and Ibogaine in Cocaine‐Seeking: Extinction Enhancement Without Relapse Prevention
Using a preclinical model of cocaine self‐administration, we examined the effects of psilocybin and ibogaine on extinction learning and relapse‐like behaviour. Both compounds, administered during the extinction phase, reduced cocaine seeking, indicating facilitation of extinction learning. However, neither treatment prevented cue‐induced reinstatement.
Isis Rita Anzel Koutrouli +16 more
wiley +1 more source
Being Wrong About Personal Transformation
Abstract Transformative experiences are thought to change us in different ways. Some transform us epistemically by providing genuinely new, previously unimaginable experiences, while others bring about personal transformation by altering our values. Recent debates on transformative experiences have explored the challenges these experiences pose for ...
Adrian Kind
wiley +1 more source

